About OBiO Technology
OBiO Technology is a company based in Shanghai (China) founded in 2013. It operates as a Professional Services, and Managed Services. OBiO Technology has raised $87.09 million across 3 funding rounds from investors including 5Y Capital, Loayal Valley Capital and Chenshan Capital. The company has 692 employees as of December 31, 2024. OBiO Technology offers products and services including Gene Therapy Vector Development, Cell and Gene Therapy CDMO, and Regenerative Medicine CDMO. OBiO Technology operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others.
- Headquarter Shanghai, China
- Employees 692 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Obio Technology (Shanghai) Corp., Ltd. Class A
-
Annual Revenue
$33.11 M (USD)19.24as on Dec 31, 2024
-
Net Profit
$-44.09 M (USD)-151.54as on Dec 31, 2024
-
EBITDA
$-30.95 M (USD)-63.12as on Dec 31, 2024
-
Total Equity Funding
$87.09 M (USD)
in 3 rounds
-
Latest Funding Round
$44.21 M (USD), Series C
Sep 23, 2020
-
Investors
5Y Capital
& 11 more
-
Employee Count
692
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OBiO Technology
OBiO Technology is a publicly listed company on the SSE with ticker symbol 688238 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OBiO Technology
OBiO Technology offers a comprehensive portfolio of products and services, including Gene Therapy Vector Development, Cell and Gene Therapy CDMO, and Regenerative Medicine CDMO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gene therapy vectors are developed for research applications.
CDMO services are provided for gene therapy drugs.
Services for regenerative medicine are offered to clients.
Funding Insights of OBiO Technology
OBiO Technology has successfully raised a total of $87.09M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $44.21 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $44.2M
-
First Round
First Round
(11 Mar 2020)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series C - OBiO Technology | Valuation | Loayal Valley Capital | |
| Jul, 2020 | Amount | Series B - OBiO Technology | Valuation | Shanghai Zhangjiang Technology Venture Capital , GP Capital |
|
| Mar, 2020 | Amount | Series B - OBiO Technology | Valuation | SIG , Efung Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OBiO Technology
OBiO Technology has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include 5Y Capital, Loayal Valley Capital and Chenshan Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on technology and innovation investments.
|
Founded Year | Domain | Location | |
|
Mid-market companies are targeted for investment by Loayal Valley Capital.
|
Founded Year | Domain | Location | |
|
Chenshan Capital is focused on data-driven industrial internet investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OBiO Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OBiO Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Obio Technology Comparisons
Competitors of OBiO Technology
OBiO Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Developer of biosimilars, vaccines and natural products
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Obio Technology
Frequently Asked Questions about OBiO Technology
When was OBiO Technology founded?
OBiO Technology was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Where is OBiO Technology located?
OBiO Technology is headquartered in Shanghai, China.
Is OBiO Technology a funded company?
OBiO Technology is a funded company, having raised a total of $87.09M across 3 funding rounds to date. The company's 1st funding round was a Series B of $14.38M, raised on Mar 11, 2020.
How many employees does OBiO Technology have?
As of Dec 31, 2024, the latest employee count at OBiO Technology is 692.
What is the annual revenue of OBiO Technology?
Annual revenue of OBiO Technology is $33.11M as on Dec 31, 2024.
What does OBiO Technology do?
OBiO Technology (Shanghai) Corp., Ltd. is focused on providing solutions in the field of cell and gene therapy. The company offers CRO services for basic research, including gene therapy vector development and drug target studies. Additionally, CDMO services are provided for the development and production of cell and gene therapy drugs, covering clinical and commercial stages. The company also supports regenerative medicine through cell preparation and storage technologies. Operating primarily in the biotechnology sector, OBiO Technology aims to advance health industries through innovative applications.
Who are the top competitors of OBiO Technology?
OBiO Technology's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
What products or services does OBiO Technology offer?
OBiO Technology offers Gene Therapy Vector Development, Cell and Gene Therapy CDMO, and Regenerative Medicine CDMO.
Is OBiO Technology publicly traded?
Yes, OBiO Technology is publicly traded on SSE under the ticker symbol 688238.
Who are OBiO Technology's investors?
OBiO Technology has 12 investors. Key investors include 5Y Capital, Loayal Valley Capital, Chenshan Capital, Kunlun Fund, and BioTrack Capital.
What is OBiO Technology's ticker symbol?
The ticker symbol of OBiO Technology is 688238 on SSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.